Neurones S.A. (EPA:NRO)
France
· Delayed Price · Currency is EUR 46.65
-0.10 (-0.21%)
Apr 24, 2025, 5:35 PM CET
Neurones Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 810.4 | 741.18 | 665.38 | 579.88 | 524.49 | Upgrade
|
| Revenue Growth (YoY) | 9.34% | 11.39% | 14.74% | 10.56% | 2.83% | Upgrade
|
| Cost of Revenue | - | 394.42 | 356.26 | 323.3 | 296.19 | Upgrade
|
| Gross Profit | 810.4 | 346.76 | 309.12 | 256.58 | 228.3 | Upgrade
|
| Selling, General & Admin | - | 248.58 | 215 | 174.75 | 154.44 | Upgrade
|
| Other Operating Expenses | 732.5 | 7.58 | 6.49 | 5.38 | 6.94 | Upgrade
|
| Operating Expenses | 732.5 | 272.06 | 236.89 | 194.93 | 176.41 | Upgrade
|
| Operating Income | 77.9 | 74.69 | 72.22 | 61.64 | 51.89 | Upgrade
|
| Interest Expense | - | -1.43 | -1.7 | -0.97 | -1.02 | Upgrade
|
| Interest & Investment Income | 10.2 | 5.92 | 1.66 | 1.15 | 1.02 | Upgrade
|
| Other Non Operating Income (Expenses) | - | - | -0.02 | - | -0.21 | Upgrade
|
| EBT Excluding Unusual Items | 88.1 | 79.18 | 72.16 | 61.83 | 51.68 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | 0.43 | 0.03 | 0 | 1.91 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | 0.83 | 0.06 | -0.3 | -0.09 | Upgrade
|
| Other Unusual Items | - | 0.33 | 0.61 | 0.23 | 0.06 | Upgrade
|
| Pretax Income | 88.1 | 80.77 | 72.86 | 61.76 | 53.56 | Upgrade
|
| Income Tax Expense | 24.9 | 22.18 | 21.09 | 18.82 | 18.58 | Upgrade
|
| Earnings From Continuing Operations | 63.2 | 58.58 | 51.77 | 42.94 | 34.99 | Upgrade
|
| Minority Interest in Earnings | -10.7 | -9.17 | -7.53 | -5.23 | -4.07 | Upgrade
|
| Net Income | 52.5 | 49.41 | 44.24 | 37.71 | 30.92 | Upgrade
|
| Net Income to Common | 52.5 | 49.41 | 44.24 | 37.71 | 30.92 | Upgrade
|
| Net Income Growth | 6.25% | 11.68% | 17.34% | 21.95% | 0.39% | Upgrade
|
| Shares Outstanding (Basic) | - | 24 | 24 | 24 | 24 | Upgrade
|
| Shares Outstanding (Diluted) | - | 24 | 24 | 24 | 24 | Upgrade
|
| Shares Change (YoY) | - | 0.10% | 0.18% | -0.13% | -0.07% | Upgrade
|
| EPS (Basic) | - | 2.04 | 1.83 | 1.56 | 1.28 | Upgrade
|
| EPS (Diluted) | - | 2.03 | 1.82 | 1.55 | 1.27 | Upgrade
|
| EPS Growth | - | 11.54% | 17.42% | 22.05% | 0.13% | Upgrade
|
| Free Cash Flow | - | 54.09 | 44.36 | 57.92 | 60.1 | Upgrade
|
| Free Cash Flow Per Share | - | 2.23 | 1.83 | 2.39 | 2.48 | Upgrade
|
| Dividend Per Share | 1.300 | 1.200 | 1.100 | 1.000 | - | Upgrade
|
| Dividend Growth | 8.33% | 9.09% | 10.00% | - | - | Upgrade
|
| Gross Margin | 100.00% | 46.78% | 46.46% | 44.25% | 43.53% | Upgrade
|
| Operating Margin | 9.61% | 10.08% | 10.85% | 10.63% | 9.89% | Upgrade
|
| Profit Margin | 6.48% | 6.67% | 6.65% | 6.50% | 5.90% | Upgrade
|
| Free Cash Flow Margin | - | 7.30% | 6.67% | 9.99% | 11.46% | Upgrade
|
| EBITDA | 85.92 | 82.72 | 79.57 | 69.42 | 59.79 | Upgrade
|
| EBITDA Margin | 10.60% | 11.16% | 11.96% | 11.97% | 11.40% | Upgrade
|
| D&A For EBITDA | 8.02 | 8.02 | 7.35 | 7.78 | 7.91 | Upgrade
|
| EBIT | 77.9 | 74.69 | 72.22 | 61.64 | 51.89 | Upgrade
|
| EBIT Margin | 9.61% | 10.08% | 10.85% | 10.63% | 9.89% | Upgrade
|
| Effective Tax Rate | 28.26% | 27.47% | 28.95% | 30.47% | 34.68% | Upgrade
|
| Revenue as Reported | - | 741.18 | 665.38 | 579.88 | 524.49 | Upgrade
|
Updated Mar 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.